Clinical Trials Directory

Trials / Conditions / Stage II Bladder Urothelial Carcinoma

Stage II Bladder Urothelial Carcinoma

7 registered clinical trials studyying Stage II Bladder Urothelial Carcinoma.

StatusTrialSponsorPhase
Active Not RecruitingGemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and S
NCT03609216
Alliance for Clinical Trials in OncologyPhase 2
WithdrawnCirculating Tumor Cells in Operative Blood in Patients With Bladder Cancer
NCT02514408
University of Southern California—
WithdrawnRobot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of M
NCT03238664
University of Southern CaliforniaN/A
WithdrawnGemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer
NCT02944357
Mayo ClinicN/A
TerminatedsEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer
NCT02767921
University of Southern CaliforniaPhase 1
TerminatedRobotic or Open Radical Cystectomy in Treating Patients With Bladder Cancer
NCT02699853
University of Southern CaliforniaN/A
TerminatedUltrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder
NCT02494635
University of Southern California—